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Background: During rat development, histamine (HA) is one of the first neuroactive molecules to appear in the
brain, reaching its maximal value at embryonic day 14, a period when neurogenesis of deep layers is occurring in
the cerebral cortex, suggesting a role of this amine in neuronal specification. We previously reported, using high-
density cerebrocortical neural precursor cultures, that micromolar HA enhanced the effect of fibroblast growth
factor (FGF)-2 on proliferation, and that HA increased neuronal differentiation, due to HA type 1 receptor (H1R)
activation.
Results: Clonal experiments performed here showed that HA decreased colony size and caused a significant
increase in the percentage of clones containing mature neurons through H1R stimulation. In proliferating
precursors, we studied whether HA activates G protein-coupled receptors linked to intracellular calcium increases.
Neural cells presented an increase in cytoplasmic calcium even in the absence of extracellular calcium, a response
mediated by H1R. Since FGF receptors (FGFRs) are known to be key players in cell proliferation and differentiation,
we determined whether HA modifies the expression of FGFRs1-4 by using RT-PCR. An important transcriptional
increase in FGFR1 was elicited after H1R activation. We also tested whether HA promotes differentiation specifically
to neurons with molecular markers of different cortical layers by immunocytochemistry. HA caused significant
increases in cells expressing the deep layer neuronal marker FOXP2; this induction of FOXP2-positive neurons
elicited by HA was blocked by the H1R antagonist chlorpheniramine in vitro. Finally, we found a notable decrease in
FOXP2+ cortical neurons in vivo, when chlorpheniramine was infused in the cerebral ventricles through intrauterine
injection.
Conclusion: These results show that HA, by activating H1R, has a neurogenic effect in clonal conditions and
suggest that intracellular calcium elevation and transcriptional up-regulation of FGFR1 participate in HA-induced
neuronal differentiation to FOXP2 cells in vitro; furthermore, H1R blockade in vivo resulted in decreased cortical
FOXP2+ neurons.
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The mammalian neocortex comprises six layers, each
containing neurons with its own morphology, functional
properties and connections as well as time of origin.
Neocortex formation during development is generated
in an inside-out pattern, with the oldest neurons (layer
VI) closest and the youngest neurons (layers II/III) far-
thest from their birthplace near the ventricle [1-4]. The
region where migration stops is defined by a layer of
specialized pioneer neurons called Cajal-Retzius cells,
which migrate tangentially early during development [5].
After development, the deepest layers of cortical neu-
rons (layers V and VI) contain neurons that interconnect
areas of the cortex or projection neurons reaching sub-
cortical structures. Layer IV is the layer where most
extracortical inputs arrive, particularly from the sensory
thalamus, whereas the superficial layers are composed
mainly of local circuits that form reciprocal connections
with the deep layers [6]. Neurons within the cortex are
born in a precise timing and this is essential for generat-
ing the final complex laminar cytoarchitecture, in which
it is possible to identify specific layer markers such as
reelin and p73 (layer I), stab2 and Cux1 (layers II/III and
IV), Tbr1, CTIP2, Sox5, Tle4, FOXP2, ER81, OTX1 and
Stab2 (layers V and VIa) and, finally, Tbr1 and CTIP2
for layer VIb [7,8].
During rat development, histamine (HA) is one of the
first neuroactive molecules to be detected in the central
nervous system (CNS), being present as early as embry-
onic day (E)12 and reaching its maximum value at E14
to E16 in the prosencephalic area [9], a five-fold higher
value relative to adult brain levels. Between E14 and
E18, fibers from the transient histaminergic neurons can
be detected in the mesencephalon, passing through the
ventral tegmental area and within the medial forebrain
bundle and the optic tract, to reach the frontal and the
parietal cortices at E15, earlier than other monoaminer-
gic systems [9-13]; this coincides with the period in
which neuronal differentiation is occurring in the cere-
bral cortex [14]. This rise in HA, together with mRNA
expression for HA receptors type 1 (H1R) and type 2
(H2R) in the developing CNS suggests a role of HA dur-
ing brain development [15].
The in vitro effects of HA on proliferation and neur-
onal differentiation of cerebral cortex neural precursor
cells (NPC) were studied by our group. We showed that
100 μM HA increases cell proliferation mainly through
H2R activation without causing premature differentiation
in the presence of fibroblast growth factor (FGF)-2 [16].
We have recently reported that HA is required in the
proliferative phase (+FGF-2) of NPC to induce neuro-
genesis [17]. After FGF-2 withdrawal, HA augmented
neuronal differentiation by H1R stimulation [16]. H1R is
a G protein-coupled receptor, which after activationproduces inositol triphosphate (IP3) and diacylglycerol,
that in turn promote an increase in [Ca2+]i due to activa-
tion of IP3 receptors in the endoplasmic reticulum, and
the activation of protein kinase C [18]. Calcium release
from intracellular stores into the cytosol is a critical
component during ontogenesis and contributes particu-
larly to the formation and maintenance of dendritic
structures [19,20].
In this report we studied whether HA-induced neurogen-
esis was present at the single-cell level by clonal analysis. In
proliferating NPC, HA induced calcium elevations medi-
ated by H1R activation. FGF receptors (FGFRs) transcripts
were up-regulated by HA in the presence of FGF-2, with
FGFR1 presenting a sustained elevation after two hours.
Cultured NPC readily differentiated to neurons that express
the deep cortical layers marker FOXP2 after HA treatment.
Antagonism of H1R in vivo during cortical development
resulted in decreased immuno-reactivity to β-tubulin III
and FOXP2.
Results
We have previously reported that NPC, before and after
differentiation, express H1R and H2R mRNA (by RT-
PCR) and their corresponding proteins (by immunoblot).
We analyzed H1R and H2R expression and its regulation
by HA at the cellular level, using specific antibodies for
these histaminergic receptors. Additional file 1 shows
that H1R and H2R are present in 81 ± 1.8% and 92 ±
2.0% of passage (P) 2 proliferating NPC, respectively.
Cultures treated with 100 μM HA for 4 days showed
very similar proportions of H1R- (83 ± 1.0%) and H2R-
positive cells (94 ± 1.4%).
Neuronal differentiation is promoted by histamine in
clonally-derived colonies
HA increases the proportion of differentiated neurons in
cortical NPC cultures, an effect mediated by H1R activa-
tion [16]. We performed experiments at clonal density,
in which HA was present all along proliferation and dif-
ferentiation phases, to establish if this neurogenic effect
was also present in colonies arising from a single cell.
Isolated individual cells were identified and allowed to
proliferate in the presence of FGF-2 for eight days,
followed by FGF withdrawal for six additional days to in-
duce differentiation. Since we observed apparent changes
in the size of colonies between the control and HA condi-
tion, we measured the area and total cell numbers per
clonal colony after crystal violet staining (Figures 1A-D).
HA caused a significant 26% decrease in colony area
(Figure 1E) and also a 16% non-significant reduction in
cell number (Figure 1F). Co-incubation of HA with the
H1R antagonist chlorpheniramine caused a significant in-
crease in both colony area and cell number, relative to
control and also to 100 μM HA. Incubation of HA with
Figure 1 HA significantly decreases clonal colony size by H1R activation. Crystal violet-stained clones were used to measure colony area
and the number of cells. (A-D) Representative composite pictures of colonies with the indicated treatment. The insets show a magnification of
the center of each colony. Note that cell size seems uniform, but in 100 μM HA + chlorpheniramine (Chlorph.) the cells are more separated from
each other. Scale bar = 250 μm for the low magnification and 100 μm for the insets. (E) Areas (mm2) quantified from crystal violet-stained clones.
HA reduces the colony’s area in a significant manner with respect to control cultures; this effect was prevented by the H1R antagonist
chlorpheniramine (Chlorph.), but not by cimetidine (Cimet.). **P <0.01 and ***P <0.001 versus Control; aP <0.01 versus 100 μM HA. (F) Cell
counting from the stained clones, showing a non-significant decrease in the total number of cells after HA treatment and a significant increase
with HA + Chlorph. *P <0.05 versus Control; ***P <0.001 versus Control; bP <0.001 versus clorpherinamine-HA. Results are the mean ± SEM from
three independent experiments made in duplicate. HA, histamine; H1R, histamine receptor type 1; SEM, standard error of the mean.
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cantly smaller than controls; cell number per colony was
also significantly decreased by cimetidine, regardless of
HA presence, relative to the control value.
We next analyzed cell fate in these clonal colonies.
Mature neurons (MAP2+) and astrocytes (GFAP+) were
detected by immunofluorescence to score the proportion
of colonies that contained mature neurons. HA in-
creased 2.8-fold the number of colonies with neurons
after differentiation (Figure 2); the HA effect was com-
pletely prevented when cultures were co-treated with
chlorpheniramine, but was insensitive to cimetidine,since no significant difference was found between HA
and HA + cimetidine conditions. Cultures treated with
the H1R or the H2R antagonist without HA, did not
show significant changes. Concerning astrocytic differen-
tiation, GFAP+ cells were detected in all clonal colonies.
Histamine causes an increase of intracellular calcium
dependent on activation of H1R in undifferentiated cells
To establish if addition of HA to NPC elicited increases
in [Ca2+]i, P2 NPC growing with FGF-2 were loaded
with the ratiometric calcium probe Fura-2 and re-plated
in glass-bottom dishes for imaging. The intracellular
Figure 2 HA activates H1R to increase the number of clones with differentiated neurons. (A) Significant increase in the number of colonies
with microtubule associated protein 2 (MAP2)+ neurons promoted by HA and its prevention by chlorpheniramine (Chlorph.) **P <0.01 and ***P
<0.001 versus Control. (B-D) Representative micrographs of clonal colonies after immunocytochemical detection of mature neurons (MAP2+; red),
astrocytes (GFAP+; green) and nuclei (blue) in Control (B), HA-treated (C) and HA + chlorpheniramine (Chlorph.)-treated (D) cells are shown. Scale
bar = 100 μm. GFAP, glial fibrillary acidic protein; HA, histamine; H1R, histamine receptor type 1.
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sion at 510 nm, resulting from alternating excitation of
Fura-2 between 340 nm and 380 nm (R = F340/F380). We
found that 65% of cells increased on average 2.2-fold the
basal [Ca2+]i in response to HA addition (Figure 3A).
Such HA-elicited rise was completely blocked by co-
incubation with chlorpheniramine (Figure 3B); cimeti-
dine did not prevent the [Ca2+]i increase produced by
HA (Figure 3D). Antagonists added before HA did not
modify the basal levels of [Ca2+]i (Figures 3B and D).
When experiments were done in the absence of extracel-
lular Ca2+, we found a small but significant 1.3-fold in-
crease in the fluorescence ratio stimulated by HA, caused
by release of Ca2+ from intracellular deposits (Figure 3C).
These results show that NPC express functional H1R,
which after activation elicit a [Ca2+]i increase.
Histamine up-regulates transcripts for FGF receptors
during proliferation
In addition to calcium signaling, regulation of FGFRs
might contribute to HA effects in neuronal commit-
ment. We therefore analyzed the expression of FGFRs in
proliferating NPC. In these experiments, cells were stim-
ulated with HA and/or histaminergic drugs, and RNA
was extracted at different time points (30, 60 or 120 mi-
nutes after treatment), followed by retrotranscriptionand endpoint PCR amplification with specific primers to
detect FGFR1, FGFR2 (isoforms IIIB and IIIC), FGFR3
and FGFR4 expression. We were able to detect all listed
FGFRs, except FGFR2-IIIB in control conditions. HA
caused a transcriptional up-regulation of FGFR1, FGFR2-
IIIC and FGFR3 in samples stimulated for 30 minutes.
The expression of FGFR1 and FGFR2-IIIC showed a bi-
phasic increase, while mRNA levels for FGFR3 showed a
progressive decline after 60 to 120 minutes (Figures 4A,
4D and 4G).
The significant increase in mRNA for FGFR1 was 5.5
times relative to control after 2 hours of HA addition.
FGFR1 up-regulation analyzed 30 minutes after HA
stimulation, was sensitive to 1 μM chlorpheniramine,
but not to 30 μM cimetidine, with neither antagonist
having an effect on its own (Figures 4B and 4C). On the
other hand, the HA-induced increase in FGFR2-IIIC
mRNA showed a different pharmacology: at 30 minutes,
neither antagonist had an effect, but after stimulation for
120 minutes, H1R or H2R antagonists were able to de-
crease FGFR2-IIIC expression to control levels (Figures 4E
and 4F). FGFR3 expression was stimulated by HA treat-
ment for 30 minutes; however, mRNA levels for this FGFR
showed a progressive non-significant decline relative to
control levels after 60 and 120 minutes (Figure 4G). At 30
minutes, the HA-elicited increase was neither prevented
Figure 3 (See legend on next page.)
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Figure 3 Increase of intracellular calcium induced by HA through activation of H1R. (A-D) Representative trace from responsive NPC to 100
μM HA, showing the average ratio (R) of fluorescence of Fura-2 alternating excitation between 340 nm (F340) and 380 nm (F380) as a measure of
[Ca2+]i. HA addition elicited a clear increase (A) that was blocked by co-incubation of HA with the H1R antagonist chlorpheniramine (Chlorph.)
(B), (C) HA added in a medium without extracellular calcium caused a discrete [Ca2+]i rise. (D) Cimetidine (Cimet.) did not block the Ca
2+
elevation caused by HA. Note that neither chlorpheniramine nor cimetidine modified basal Ca2+ levels. (E-P) Representative images from the
same experiment in A to D at different times: before the stimulus (E, H, K, N), after HA addition (F, I, L, O) and 80 seconds after the stimulus
was given (G, J, M, P). Chlorpheniramine and cimetidine were incubated during the five minutes prior to HA addition. The bar on the side of
image E indicates the scale for R = F340 / F380. (Q) Average values of ratiometric Fura-2 measurements, expressed as a percentage of the basal
(before stimulus) value are presented in the graph as the mean ± standard error from three to five independent experiments. ***P <0.0001 versus
100 μM HA and also versus 100 μM HA + Cimet.; aP <0.01 versus 100 μM HA without extracellular Ca2+. HA, histamine; H1R, histamine receptor
type 1; NPC, neural precursor cells.
Figure 4 HA up-regulates FGFRs transcripts. RT-PCR analysis of the effect of 100 μM HA on FGFRs expression. Kinetics of the effect of HA on
FGFR1 (A), FGFR2-IIIC (D) and FGFR3 (G) expression, normalized by GAPDH; the increases are presented as percentage of the expression obtained
in control conditions for each time point. **P <0.01 and ***P <0.001 versus control. (B) Pharmacological analysis of HA effect on FGFR1
expression at 30 minutes. The H1R antagonist chlorpheniramine (Chlorph.) prevented the increase in FGFR1 expression caused by HA, whereas
cimetidine (Cimet.) was uneffective. (E) FGFR2-IIIC expression significantly increased after 120 minutes of HA treatment; both chlorpheniramine
and cimetidine were able to block such increase. (H) HA increased FGFR3 transcripts, but such elevation was not sensitive to either
chlorpheniramine or cimetidine. **P <0.01 versus control; aP <0.01 versus its corresponding condition in the absence of HA. (C, F and I)
Representative bands for the conditions shown in B, E and H, respectively, including a positive control (adult cerebral cortex) and PCR in the
absence of retrotranscription (−RT). FGFRs, fibroblast growth factor receptors; HA, histamine.
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Although we observed FGFR4 expression in control condi-
tions, 100 μM HA, alone or in combination with H1R or
H2R antagonists, did not significantly change such levels at
the studied time points (data not shown).
Histamine increases FOXP2 neurons after differentiation
of cultured NPC
In order to investigate if HA selectively induces specific
neuronal phenotypes, we performed immunocytochem-
ical detection of some markers characteristic of specific
cortical layers after six days of differentiation. We used
the following laminar markers (Figure 5A): p73 (Cajal-
Retzius neurons), reelin (Cajal-Retzius neurons and subplate
neurons), calretinin (Cajal-Retzius and subplate neurons),
CUX1 (upper layer neurons) and FOXP2 (deeper layer neu-
rons), together with the mature neuronal protein MAP2. As
previously reported by our group, 100 μM HA caused a 2.7-
fold increase in the number of MAP2+ cells (Figure 5B).
We did not find, in control nor in HA-treated cultures,
Cajal-Retzius neurons, since we did not observed any p73+
cells, although there were calretinin+ and reelin+ cells; such
cells positive for calretinin and reelin might correspond to
subplate neurons. Particularly the calretinin+ population
was significantly increased (1.6-fold) in HA-treated cultures
when quantified as cells expressing this marker relative to
the total cell number (Figure 5B). However, given that the
number of neurons also increased significantly after HA
addition, we calculated the percentage of MAP2+ cells that
also express calretinin. Surprisingly, HA caused a signifi-
cant decrease in the proportion of calretinin+ neurons
(Figure 5C). The molecular marker for the upper layer
neurons CUX1 was not detected in control cultures, but
CUX1+ cells were present in cultures treated with HA, al-
though at a low proportion and with none of them co-
expressing MAP2. HA did not affect the percentage of
gamma-aminobutyric acid (GABA)+ cells after differenti-
ation; these GABA-positive cells might be immature neu-
rons, since they do not express MAP2.
A significant 1.5-fold increase was observed in the
number of cells expressing the deep layer marker
FOXP2 after HA addition, when quantified as the per-
cent of total cells. This significant increase is also
present when we analyzed the proportion of FOXP2+
cells that express MAP2 (Figure 5C), thus resulting in
more neurons and a higher percentage of neurons that
express FOXP2 after HA treatment.
H1R antagonism prevents the induction of FOXP2
neuronal phenotype by histamine in cultured NPC and
decreases the number of FOXP2 neurons in the cortical
neuroepithelium in vivo
To investigate if the increase in the proportion of
FOXP2+/MAP2+ cells caused by HA was sensitive tothe H1R antagonism, we performed experiments in
which co-incubation of HA and chlorpheniramine was
made. This resulted in abolition of FOXP2 induction,
with the antagonist alone having no effect relative to
control conditions (Figures 6A to 6E). To study if activa-
tion of H1R might play a role during cortical develop-
ment in vivo, we set up a system for intrauterine
injection of E12 embryos in the lateral ventricles. Two
days later, the dam was euthanized and the developing
embryos recovered and analyzed by immunohistochem-
istry. In vehicle-injected animals, we found neurons ex-
pressing β-tubulin III that were also positive for FOXP2
(Figures 6F and 6G). However, after injection of 25 μg of
chlorpheniramine, there was an apparent decrease in
both β-tubulin III and FOXP2+ cells (Figure 6H), with-
out obvious alterations in the cortical area. This effect
seems to be specific for the developing cortex, because
embryos that received the same amount of chlorphenir-
amine did not suffer a decrease in β-tubulin III staining
in the midbrain (Escobedo-Ávila et al., unpublished
observations).
Discussion
NPC are useful to study the role of a number of factors
affecting self-renewal, proliferation and cell fate in vitro
and also can guide researchers on the compounds to be
tested in vivo. We have previously reported, using cor-
tical NPC, that HA increases cell division during the
proliferative phase, in the presence of FGF-2, mainly
through H2R activation without affecting the high pro-
portion of Nestin-positive cells, a marker used for neural
stem and precursor cells; after differentiation, this amine
increases the proportion of neurons by H1R activation
[16]. In this work, we show that: (i) HA, through H1R
stimulation, decreases the area of clonal colonies and in-
creases the proportion of colonies containing mature
neurons after differentiation of NPC; (ii) HA promotes
an increase in [Ca2+]i by H1R activation in proliferating
neural cells; (iii) HA receptor activation up-regulates
FGFR1 and FGFR2-IIIC expression during proliferation;
(iv) HA promotes differentiation of cultured NPC into
FOXP2-positive neurons by H1R stimulation; and (v)
blockade of H1R in vivo results in decreased numbers of
FOXP2 neurons in the developing rat cerebral cortex.
To test if HA was able to induce neuronal commit-
ment at the single cell level, we performed clonal ana-
lysis, the most stringent assay to test for differentiation
potential in vitro. Whereas HA treatment produced a
noticeable decrease in the size of colonies, incubation of
HA+chlorpheniramine significantly increased the area of
the colonies in relation to control and HA-treated cells.
Cimetidine, on the other hand, did not antagonize HA ac-
tion (Figure 1E). To investigate if these changes in colony
area were related to variations in the total cell numbers
Figure 5 HA induces differentiation of NPC to FOXP2 neurons. (A) Modified scheme illustrating the expression of layer-specific markers in
cortical neurons, their timing of generation in vivo and regions of projection [8,21,22]. (B) Quantification of the total number of mature neurons
(MAP2+) and detection of specific cortical laminar neuronal phenotypes. *P <0.05 and ***P <0.001. (C) Percentage of MAP2-positive neurons that
express FOXP2 or calretinin. Note that the proportion of FOXP2+ neurons increased whereas calretinin+ neurons decreased after HA treatment.
*P <0.05 versus FOXP2 without HA; ###P <0.001 versus calretinin without HA. (D-O) Representative micrographs of immunofluorescence detection
of the indicated markers in control (D, F, H, J, L and N) and HA-treated (E, G, I, K, M and O) cells. Nuclei were labeled with Hoechst and are
shown in blue. Scale bar = 100 μm. HA, histamine; MAP2, microtubule associated protein 2; NPC, neural precursor cells.
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amine and cimetidine, each added alone, significantly de-
creased cell numbers. The increase caused by HA was
sensitive to chlorpheniramine, but not to cimetidine
(Figure 1E). Images taken from the center of the colonies
(Figures 1A to 1D) show that individual cells have similarsizes, but in the HA+ chlorpheniramine condition, cells
were more disperse, suggesting that specific activation of
H2R might promote migration/motility. On the other
hand, H1R activation (HA+cimetidine) could be respon-
sible for the compaction of the clonal colony. Further re-
search is needed to elucidate these intriguing effects.
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NPC shifts from neurogenic to astrocytogenic after sev-
eral passages, similar to what happens in high-density
cultures [23]. We show that HA is able to significantly
increase neuronal differentiation, as measured by the
proportion of colonies containing mature (MAP2+) neu-
rons. The neuronal-promoting action of HA was also
dependent upon activation of H1R, since this effect was
sensitive to chlorpheniramine, but not to cimetidine. We
also analyzed astrocytic differentiation in clonal cultures.
Although at higher cell density, HA reduces the propor-
tion of astrocytes [16], we found GFAP+ cells in all
clonal colonies, indicating that neither HA nor its antag-
onists precluded astroglial commitment, and that theFigure 6 Chlorpheniramine prevents FOXP2 neuronal differentiation
positive for FOXP2 after HA stimulation of cultured NPC. This induction wa
*P <0.01 versus all the remaining conditions. (B to E) Representative micro
chlorpheniramine (D) and chlorpheniramine alone (E). (F to H) Effect of inj
analyzed two days later. (F) Scheme of a coronal section from an E14 rat te
line represents the section of the dorsal telencephalon used for in vitro exp
with antibodies for β-tubulin III and FOXP2. In control conditions (G), nume
25 μg of chlorpheniramine (H), a decrease in both β-tubulin III and FOXP2
chlorpheniramine-injected embryos from different dams. Scale bar = 100 μ
protein 2; NPC, neural precursor cells.differentiation potential of a single NPC is conserved in
the presence of HA. Therefore, HA seems to be promot-
ing differentiation with neuronal bias in clonal cultures
through activation of H1R.
Changes in [Ca2+]i play diverse roles in nervous system
development including differentiation of neural cells
[24,25], chemotaxis [26,27], proliferation [28] and morph-
ology [29]. Although a high proportion of NPC in our cul-
tures expresses H1R (81%), only 65% express functional
receptors, as shown by the increase in [Ca2+]i promoted
by HA. The increase in [Ca2+]i due to HA was completely
blocked by chlorpheniramine and significantly reduced in
the absence of extracellular Ca2+. Activation of H1R leads
to the production of IP3 and diacylglycerol, that in turnin vitro and in vivo. (A) Significant increase of mature MAP2+ neurons
s blocked by co-incubation of HA with chlorpheniramine (Chlorph.).
graphs for control (−HA, B), 100 μM HA (C), 100 μM HA + 1 μM
ection of chlorpheniramine in E12 developing rat brains that were
lencephalon. The arrow represents the area used for analysis. The red
eriments. (G and H) Representative images of coronal sections stained
rous cells are positive for these markers. In contrast, after injection of
was found. This effect was observed in four control and four
m. E, embryonic day; HA, histamine; MAP2, microtubule associated
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ceptors in the endoplasmic reticulum, and activation of
protein kinase C; our results following HA addition in the
absence of Ca2+ in the extracellular medium strongly sug-
gest that cultured NPC activate this intracellular-mediated
Ca2+ increase. Calcium release from intracellular stores
into the cytosol is a critical component during ontogenesis
[19,20], and this HA-induced Ca2+ rise might contribute
to neuronal commitment, with the involvement of several
Ca2+-activated protein kinases and transcriptional regula-
tion [30]. HA also increases [Ca2+]i through H1R activa-
tion in undifferentiated mouse embryonic carcinoma
pluripotent cells [18]. Recently, mouse embryonic stem
cells were engineered to express a Ca2+-sensitive protein,
and HA was used to select clones that augmented [Ca2+]i,
confirming the presence of histaminergic G-protein
coupled receptors in pluripotent stem cells. Furthermore,
neural differentiation of these embryonic stem cells ren-
dered cells that also were able to increase [Ca2+]i after
addition of 100 μM HA; all these effects were mediated by
H1R [31], which is consistent with our findings.
The response of cells to FGFs during CNS develop-
ment is mediated by membrane high-affinity FGFRs
[32,33]. In particular, FGF-2 binds preferentially to
FGFR1 and FGFR2, and with less affinity to FGFR3.
FGF-2 knockout mice have only half of the neural pre-
cursor population when neurogenesis begins, leading to
a loss of pyramidal neurons in the anterior cerebral cor-
tex and to a dramatic decrease of glutamatergic cortical
neurons in the adult brain [34-36]. In agreement, expres-
sion of a dominant negative form of FGFR1 in the dorsal
telencephalic and mesencephalic areas from E9.5 on-
wards, revealed abnormalities in the medial prefrontal
cortex and temporal cortical regions. A 30% to 40% re-
duction in cortical thickness which particularly affected
the lower cortical layers was reported. This was accom-
panied by a reduction in cell number and neuronal
soma size, shorter dendritic processes, as well as a
marked reduction in the number of glutamatergic neu-
rons from layer VI with no effects on GABAergic inter-
neurons [37].
Regulation of FGFRs can participate in both prolifera-
tion and commitment of NPC. Our results using RT-
PCR show that NPC express all FGFR tested, with the
exception of FGFR2-IIIB, and that the expression of
FGFR1 and FGFR2-IIIC were up-regulated at 30 and
120 minutes by HA with a transient decrease at 60 mi-
nutes. These changes might be explained by H1R
desensitization, which occurs after 30 minutes and is re-
lieved after 120 minutes in cerebral brain slices from
adult rodents [38]. Previous studies demonstrated that
FGFR1 mRNA is expressed in the dorsal ventricular
zone (VZ), the primordium of the cerebral cortex [39].
FGFR2-IIIC expression is particularly restricted to theVZ of the basal forebrain and other ventral structures
where proliferation of precursors occurs [40]. FGFR3
and FGFR4 are strongly expressed in the VZ during
CNS development, but at later stages, FGFR3 expression
appears largely confined to glia [41,42]. We propose that
HA stimulation of H1R regulates FGFR1 expression and
these effects might be related to neuronal differentiation
since the transcriptional increases of FGFR1 were sensi-
tive to H1R blockade, and FGFR1 mRNA showed the
highest increase (550% relative to control levels) after
two hours of HA exposure.
It has been shown that [Ca2+]i and FGFR activation
are tightly related. FGF-2, but not epidermal growth fac-
tor, causes an increase in [Ca2+]i, which later on is corre-
lated with neuronal differentiation in telencephalic
neural precursors [43]. In addition, other factors might
contribute to HA-induced neurogenesis. Our recent re-
sults [17] suggest that the HA neurogenic effect is at the
level of cell commitment rather than a terminal differen-
tiation effect: HA present only during differentiation of
cortical NPC did not result in increased neuronal differ-
entiation [17]. One of the underlying mechanisms for
the neurogenic effect of HA includes increased expres-
sion of Prox1 and Neurogenin1 in the presence of FGF-2,
which implies a HA-induced neuronal commitment. Ac-
cordingly, results reported recently indicate that HA in-
duces neuronal differentiation from cultured mouse
subventricular zone stem/progenitor cells by H1R activa-
tion, an effect that involves increased expression of
Mash1, Dlx2 and Neurogenin1 [44]. Regarding differenti-
ation of neurons in the cerebral cortex, several studies
have implicated the participation of FGFR1 [37] and Prox1
in neuron commitment and differentiation [45,46].
We found that HA, in addition to enhancing neuronal
differentiation monitored through MAP2 expression, is
also able to increase significantly the proportion of the
neuronal population expressing the deep layer marker
FOXP2 in cultured NPC. Calretinin, a marker that in
principle is augmented after HA treatment when we an-
alyzed the total number of cells, actually decreased when
we calculated the proportion of calretinin+/MAP2+ cells
before and after HA (Figure 5C). Thus, HA specifically
caused increased numbers of FOXP2+ neurons. This in-
duction was completely abolished by chlorpheniramine,
identifying H1R as responsible for this effect.
The main source of cortical neurons is the neuroepi-
thelium of the VZ, where precise timing generates first
the deep layer (IV to VI) neurons (E11.5 to E14.5),
followed by more superficial neurons (layers II/III),
starting at E13.5 and ending at E16.5 (Figure 5A) [8,47].
HA concentration in the prosencephalon appears at E12
and peaks at E14 to E16 [9], suggesting a role of this bio-
genic amine on timing generation of specific types of
neurons. Messenger RNA for histaminergic receptors
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by in situ hybridization [48-50]. In particular, the cerebral
cortex expresses H1R during development [48]. Intrauter-
ine injection of chlorpheniramine in the lateral ventricles
in E12 rat embryos precluded the expression of both
β-tubulin III and FOXP2, suggesting a role of H1R dur-
ing cerebral cortical development.
Conclusions
In the present study we demonstrate that the neurogenic
effect of HA by stimulation of H1R is present in clonal
density cultures; we also show that H1R-induced neuronal
differentiation correlates with an increase in [Ca2+]i and
the up-regulation of FGFR1. Interestingly, we found that
100 μM HA promotes differentiation of cerebrocortical
NPC into FOXP2 neurons; in agreement, H1R antagonism
in vivo interferes with β-tubulin III and FOXP2 immuno-
reactivity in the developing cerebral cortex.
Methods
Cell culture
Animal procedures were approved by the local Animal
Care and Use Committee and complied with local (NOM-
062-ZOO-1999) and international guidelines (Animal Wel-
fare Assurance A5281-01). In order to obtain multipotent
NPC [51], E14 embryos were extracted from pregnant
Wistar rats and cerebral cortices were dissected in Krebs
solution (100 mM NaCl, 2 mM KCl, 0.6 mM KH2PO4, 12
mM NaHCO3, 2.2 mM MgSO4, 7 mM glucose, 0.1% phe-
nol red and 0.3% bovine serum albumin). The tissue was
mechanically dissociated to a single cell suspension. Cells
were recovered by centrifugation, re-suspended and cul-
tured on plasticware previously treated with 15 μg/mL
poly-L-ornithine (Sigma, St. Louis, MO, USA) and 1 μg/ml
human fibronectin (Invitrogen, Carlsbad, CA, USA) in
fully defined N2 medium containing 10 ng/ml FGF-2
(Peprotech, Rocky Hill, NJ, USA) as mitogen. Passage (P)
of cells was made with 0.1 mM ethylenediaminetetraacetic
acid (EDTA) in PBS. P2 cells were maintained during eight
(clonal) or four (high density) days in proliferative control
(N2 medium + 10 ng/ml FGF-2) and experimental (N2
medium + 10 ng/mL FGF-2 + 100 μM HA alone and/or
HR antagonist) conditions. Cells were seeded at low (1 x
103 cells in 6-cm plates; clonal experiments), standard (1 x
104 cells in 24-well plates for phenotype analysis) or high
density (3 x 104 in 6-well plates for mRNA expression
analysis). Differentiation was promoted by removing FGF-
2 and keeping the cells for six days in N2 medium + 200
μM ascorbic acid in the presence or absence of HA and/
or HR antagonists. In both high-density and clonal experi-
ments, HA and/or HR antagonists were present during
both proliferation and differentiation stages.
HA H1R and H2R antagonists were used, in combin-
ation with 100 μM HA, to establish if such receptorswere responsible for HA effects in clonal cultures, and
to establish the participation of these histaminergic re-
ceptors on cell differentiation phenotypes. Chlorphenir-
amine (Sigma) was used as a H1R antagonist at 1 μM
and as a H2R antagonist we used cimetidine at 30 μM
(Sigma). H1R and/or H2R antagonists were added to
control and 100 μM HA-treated cells during prolifera-
tion and differentiation phases. We also studied the ef-
fects of these antagonists on FGFRs expression at the
end of proliferation phase.
For clonal analysis, reported procedures were followed
[51]. In brief, P2 dissociated cells plated at 1,000 cells/6-
cm dish were allowed to attach for three hours. After-
wards, 15 to 20 well-isolated cells were identified by a
marking objective (Nikon, Tokyo, Japan) with a 1.8 mm
circle. Only clones arising from single cells were ana-
lyzed. To make sure there was no contribution of mi-
grating cells to the colony, the marked areas were
monitored on a daily basis to detect cells coming close
to the borders of the circle. A total of 5 to 7 clones in
duplicate (10 to 14 colonies per experiment, n = 4 to 5)
were analyzed.
Immunocytochemistry and immunohistochemistry
Previously reported standard procedures were used
[16,52]. Differentiated P2 cortical cells or tissue slices
were fixed with 4% paraformaldehyde in PBS, pH 7.4 for
20 minutes at 4°C, permeabilized and blocked for 1 hour
with 0.3% triton X-100 and 10% normal goat serum
(NGS) in PBS. Samples were incubated overnight at 4°C
with the following primary antibodies diluted in PBS
containing 10% NGS: rabbit polyclonal anti-GFAP (1:2000,
DAKO, Carpinteria, CA, USA); mouse monoclonal anti-
body anti-MAP2 (1:500, Millipore, Billerica, MA, USA);
anti-β-tubulin III (1:2000, Covance, Princeton, NJ, USA);
rabbit polyclonal anti-H1R (1:500, Santa Cruz Biotechnol-
ogy, Dallas, TX, USA); goat polyclonal anti-H2R antibody
(1:500, Santa Cruz Biotechnology); anti-Forkhead box 2,
(FoxP2; 1:1000, Sigma); anti-reelin (1:600, Millipore); anti-
Cut-like homeobox 1 (CUX1; 1:100, Sigma), anti-calretinin
(1:1000, Swant, Marly, Switzerland), anti-tumor protein
p73 (p73; 1:450, Santa Cruz Biotechnology), and anti-
GABA (1:1000, Sigma). Alexa-Fluor 488 goat anti-rabbit
immunoglobulin G (IgG) and Alexa 568 goat anti-mouse
IgG were used as secondary antibodies (1:500; Invitrogen)
diluted in PBS/10% NGS. Nuclei were stained with
Hoechst 33258 (1 ng/ml; Sigma). Immunostainings were
visualized and photographed with an epifluorescence
microscope. Negative controls without primary antibodies
did not show unspecific staining (data not shown).
Cell counting
Cell counts from immunocytochemical stainings were
performed in pictures taken with a Nikon digital camera
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of cells was performed by counting the number of
Hoechst stained nuclei (total cells) and the specified
markers in at least eight random fields, from three to
four independent experiments made in duplicate.
For clonal experiments, single cells were marked three
hours after seeding and let to proliferate for eight days,
followed by six days of differentiation. Immunodetection
of MAP2 and GFAP was performed. Results are expressed
as the percentage of colonies containing MAP2+ neurons,
relative to total clonal colonies. In order to estimate the
total number of cells in each clone, as well as to measure
the area occupied by every colony, cultures were fixed in
10% formol-PBS, pH 7.4, washed and incubated with a
0.5% solution of crystal violet for 10 minutes at 21°C. After
thorough washing with bi-distilled water, the number of
cells from clonal colonies was counted, and the area of
each clonal colony was measured from four to six experi-
ments. For cell counting and area measurement, micro-
photographs were taken of single clones and merged in
composite images with Adobe Photoshop software and
analyzed with the aid of ImageJ software.
Intracellular calcium measurements
To study changes in intracellular calcium ([Ca2+]i) induced
by 100 μM HA, undifferentiated NPC were loaded for 40
minutes at 37°C in N2 medium with 5 μM Fura-2 AM,
which diffuses across the cell membrane and is de-
esterified by intracellular esterases to yield the ratiometric
calcium probe Fura-2. Cells were detached, centrifuged
and seeded at 1 x 105 cells per 3.5-cm culture dishes with
glass bottom (MatTek Corporation, Ashland, MA, USA),
previously treated with 15 μg/ml poly-L-ornithine (Sigma)
and 1 μg/ml human fibronectin (Invitrogen) in N2
medium. After 2 hours, attached cells were incubated at
37°C in Hank’s solution (137 mM NaCl, 5 mM KCl, 0.3
mM NaH2PO4, 0.8 mM MgSO4, 1 mM MgCl2, 5 mM
CaCl2, 5 mM glucose, 2 mM glutamine, 10 mM Tris–HCl,
pH 7.4) for 10 minutes; after this stabilization time, Hank’s
solution was substituted by Hank’s with Ca2+ (5 mM) or
without Ca2+, according to the experimental paradigm.
Changes in [Ca2+]i were monitored through ratiometric
Fura-2 fluorescent signal after excitation alternating be-
tween 340 and 380 nm and emission set at 510 nm in a
Carl Zeiss Live Cell Imaging system using AxioVision soft-
ware at 37°C. Analysis of images was made offline by calcu-
lating the emission ratio generated by excitation at 340 nm
divided by that measured at 380 nm (R = F340/F380). HR
antagonists were added 5 minutes before HA stimulus and
were maintained during HA stimulation.
RNA extraction and RT-PCR
RNA was isolated from non-differentiated cultures using
TRIZOL (Invitrogen). In order to have enough RNA,NPC were seeded at 3 x 104 cells per well in 6-well
plates, incubated with FGF-2 for four days, and treated
at that point (time zero) with histaminergic compounds.
Total RNA was extracted after 30, 60 or 120 minutes.
RNA (1 μg) was reverse-transcribed with random hexamers
and 500 to 800 ng from the RT reaction were used for PCR
containing 2 U of Taq DNA polymerase (Invitrogen), 20
pmol of specific primers (Sigma; sequences listed below),
500 μM deoxynucleoside triphosphates and 1.5 mMMgCl2.
Forward (F) and reverse (Rev) primer sequences (all in
50-30orientation) used for cDNA amplifications were as
follows: FGFR1, F: CAACTggCTgCgggATgggg, Rev: gC
gCCACAggCCTACggTTT (266 bp); FGFR2-IIIB, F: gg
TCCTgAAgCACTCggggA, Rev: gCTAgCATCggggTgT
CCgC (456 bp); FGFR2-IIIC, F: CCTgAAggCCgCCgg
TgTTA, Rev: CAgggggATgCgCTTggTCA (340 bp);
FGFR3, F: gTgTggTgCCCTCTgACCgC, Rev: CACgCT
gCCAgCCTCgTCAA (467 bp); FGFR4, F: CCCggCA
TCCCAgTggAggA, Rev: gTTggAgTCCCACggCCACg
(392 bp); glyceraldehyde phosphate dehydrogenase (GAPDH),
F: ATCACCATCTTCCAggAgCG, Rev: CCTgCTTCACCAC
CACCTTCTTg (573 bp).
For FGFR3 and FGFR4, amplification was made as fol-
lows: denaturalization at 95°C for 15 minutes, 30 cycles
of denaturalization at 95°C for 1 minute, annealing at
62°C for 1 minute, and elongation at 72°C for 1 minute;
for FGFR1 and FGFR2IIIC: denaturalization at 95°C for
15 minutes, 30 cycles of denaturalization at 95°C for 1
minute, annealing at 60°C for 1 minute, and elongation
at 72°C for 1 minute; for FGFR2IIIB: denaturalization at
95°C for 15 minutes, 30 cycles of denaturalization at
95°C for 1 minute, annealing at 64°C for 1 minute, and
elongation at 72°C for 1 minute. Final extension at 74°C
for 10 minutes was terminated by rapid cooling at 4°C.
Since we were not able to detect any FGFR2-IIIB expres-
sion, nested PCR reactions were performed, but we were
still unable to see any amplification.
PCR products were analyzed in 2% agarose gel electro-
phoresis and the size of the reaction products was deter-
mined by comparison with molecular weight standards after
ethidium bromide staining. Expression analysis was made by
endpoint RT-PCR. Signals from the products obtained from
the RT-PCR reactions were quantified by densitometry using
ImageJ software (NIH). FGFRs expression was normalized
to GAPDH expression assessed from the same cDNA in
parallel PCR reactions and loaded in the same gels. The
standardized optic density mean of each triplicated PCR was
then expressed relative to the levels of GAPDH. As a nega-
tive control for PCR amplification, reactions with RNA in
the absence of retro-transcription were included. The posi-
tive controls consisted of RNA extracted from adult cerebral
cortex (FGFR1 and FGFR2-IIIC) or kidney (FGFR2-IIIB,
FGFR3 and FGFR4), which were used to synthesize cDNA
and amplified by PCR as described above.
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were recovered from gels using the Qiaquick gel extrac-
tion kit (Qiagen, Germantown, MD, USA) according to
the manufacturer’s instructions. These bands were se-
quenced at the Molecular Biology Unit in our Institute,
and it was confirmed that all bands correspond indeed
to FGFR.
In vivo intrauterine injection of embryos
To study the effect of the H1R antagonist chlorphenir-
amine on cortical development in vivo, we used an ultra-
sound (Ultraview MHF-1) imaging device coupled to a
microinjection system to introduce 2 μl of injectable
water (control) or the same volume containing 25 μg of
chlorpheniramine into the embryo’s telencephalic ventri-
cles at E12 as described [53]. Briefly, the dam was placed
in an airtight anesthesia chamber with 3% sevoflurane
(Abbott Laboratories, Abbott Park, IL, USA) in 95% O2-
5% CO2 gas mixture. The rats were maintained with a
mask of inhaled anesthesia in 0.5% to 1.5% sevoflurane
on a heating pad. The skin was shaved and aseptically
prepared to make an incision in the abdominal skin and
muscle. The uterine horns were exposed and a single
embryo was secured to proceed with injection using a
glass needle. The lateral ventricles were visualized while
making the injections and embryos were identified by
their position in the uterine horn. After 48 hours, the
dam was euthanized and the E14 embryos were recov-
ered. Only embryos that had a beating heart were se-
lected for further analysis. After fixation with 4%
paraformaldehyde in PBS (pH = 7.4) for 24 to 48 hours
at 4°C, embryos were cryoprotected with 30% sucrose
and rapidly frozen using liquid nitrogen. Coronal slices
(20 μm) were obtained and stained with antibodies that
recognize β-tubulin III or FOXP2.
Statistics
All data are presented as mean ± standard error of the
mean (S.E.M). One-way analysis of variance (ANOVA) was
performed for statistical analysis, multiple comparisons
were made using the post-hoc Student-Newman-Keuls test
to compare data; for mRNA expression analysis we used
the Dunnett test, in order to compare the experimental
condition versus its corresponding control. Differences
were considered statistically significant at P <0.05. Graphs
and statistical analysis were performed using GraphPad
and GraphPad Instat software respectively.
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Additional file 1: Title: Proliferating NPC expresses H1R and H2R.
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